According to the US FDA (https://www.fda.gov/industry/medical-products-rare-diseases-and-conditions/designating-orphan-product-drugs-and-biological-products). "NV-387 ...

According to the US FDA (https://www.fda.gov/industry/medical-products-rare-diseases-and-conditions/designating-orphan-product-drugs-and-biological-products). “NV ...

Kiniksa transitions from survival risk to growth, targeting dominance in the pericarditis market with robust cash flow and expanding margins. KNSA's Arcalyst drives revenue growth, with 2026 guidance ...

Getting good at LeetCode Java isn’t just about solving problems; it’s about having a good plan. You need to know where to start, what tools to use, and how to keep going when things get tough. This ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Cory Benfield discusses the evolution of ...

SHELTON, CT, December 9, 2025 (EZ Newswire) -- NanoViricides, Inc. (NYSE American: NNVC, opens new tab) (the “Company”) today reported that it has received approval to start a Phase II clinical trial ...

SYDNEY—Australia’s government said it would block a $387.2 million takeover of Mayne Pharma MYX3.77%increase; green up pointing triangle by U.S. company Cosette Pharmaceuticals on national security ...

LONDON, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) (Kiniksa), a biopharmaceutical company developing and commercializing novel therapies for diseases ...

Kiniksa Pharmaceuticals International said the Food and Drug Administration has granted orphan drug designation to KPL-387 for the treatment of pericarditis, which includes recurrent pericarditis. The ...

Los Angeles Housing Department launches its largest-ever affordable housing funding round, offering $387 million to developers starting Friday. The majority comes from Measure ULA’s “mansion tax” on ...